— Know what they know.
Not Investment Advice

SGEN NASDAQ

Seagen Inc.
1W: +0.0% 1M: +7.3% 3M: +6.1% 1Y: +72.9% 3Y: +15.6% 5Y: +321.2%
$228.74
Last traded 2023-12-22 — delisted
NASDAQ · Healthcare · Biotechnology · $43.2B mcap · 130M float · 1.26% daily turnover

Cash Flow Trends

Operating Cash Flow
-$454M +9.1% ▲
Capital Expenditures
$77M -47.8% ▼
5Y CAGR: +1.9%
Free Cash Flow
-$531M +3.7% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$101M +24.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
— Operating Activities —
Net Income-$223M-$159M$614M-$674M-$610M
Depreciation & Amort.$26M$34M$63M$79M$82M
Stock-Based Comp.$79M$127M$147M$173M$221M
Change in Working Capital-$52M-$113M$43M-$88M-$151M
Other Non-Cash Items-$10M-$53M-$9M$11M$3M
Operating Cash Flow-$204M-$164M$857M-$499M-$454M
— Investing Activities —
Capital Expenditures-$21M-$71M-$82M-$52M-$77M
Acquisitions (Net)-$598M-$786M-$952M-$3.8B$0
Investment Purchases-$512M-$993M-$2.5B-$3.4B-$2.5B
Investment Sales$539M$786M$1.1B$3.8B$2.8B
Other Investing$0$786M$952M$3.8B-$20M
Investing Cash Flow-$593M-$278M-$1.4B$289M$228M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$713M$638M$846M$78M$125M
Financing Cash Flow$713M$638M$846M$78M$125M
Net Change in Cash-$83M$196M$284M-$134M-$101M
Cash End of Period$78M$275M$558M$425M$323M
Free Cash Flow-$225M-$234M$774M-$551M-$531M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms